WILMINGTON, Mass. and DUBLIN, Ireland—February 10, 2025—Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus...

From Deciphex on LinkedIn: 🚨 Don’t Miss Our Upcoming Webinar! 🚨 Join us for the second webinar in our series with Charles River Laboratories, where we’ll reveal the results of a time and motion study on Patholytix Foresight!...

Charles River and Deciphex: Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices April 11, 2024 08:00 AM Eastern Daylight Time WILMINGTON, Mass....

        WILMINGTON, MA and DUBLIN, Ireland March 30 2020 -- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in...